Across TCGA pan-cancer cohorts, KRT8P42 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated KRT8P42 data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher KRT8P42 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRT8P42 expression acts as an unfavorable survival marker, although some lineages such as DLBC and LUSC show a favorable association.
COAD, UCEC, and DLBC are the cancer types where KRT8P42 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.